T1D Exchange and their First Annual Diabetes Innovation Challenge
This is exciting! T1D Exchange and M2D2, a joint venture of the University of Massachusetts Lowell and Worcester campuses that incubates medical device start-ups, have announced the first annual Diabetes Innovation Challenge (2016)....
Clinical Trial OPEN: Liver-Targeted Insulin More Effective than Insulin?
Trial name: Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects Diabetes type: Type 1 diabetes What the trial is testing: This six-month study will test the safety and efficacy of HDV insulin, a new technology that directs meal-time rapid-acting insulin...
Savvy Updates 8/20/2016: Gut Microbiome, Glucagon, UCI’s Dr. Lakey, 3-Drug Combo for Control
Relationship between the composition of the gut microbiome and diabetes is being demonstrated repeated in studies, as reported in Endocrinology Advisor by Tori Rodriguez, August 11, 2016. In a twin study by researchers at Harvard Medical School, MIT and Seoul National...
Savvy Updates 7/21/2016: CGM Benefits Shot Takers, Sleep & Diabetes Risk, Human Gut Microbiome, Intensive BG Control and Kidneys
CGM Benefits Injection Users, according to the results from Dexcom’s DIaMonD Study, presented at the ADA Scientific Sessions in June, 2016 and reported by www.diaTribe.org, 6/28/2016. According to Dr. Howard Wolpert of the Joslin Diabetes Center, healthcare providers...
Savvy Updates: 5/30/2016: T1 and Bacteria, 90-day CGM, Lab Beta Cells, & MORE
Type 1 Diabetes May Be Triggered by Bacteria Reported by Honor Whiteman, MedicalNewsToday.com, 5/17/2016 A study by researchers from Cardiff University in the UK suggests that a part of a bacterium that activates killer T cells may cause them to bind to beta cells and...
More Diabetes Blogs